down arrow

Hangzhou Alltest Biotech Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000053G6
CNY
63.59
0.58 (0.92%)

Dec 19

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Hangzhou Alltest Biotech Co., Ltd.
Why is Hangzhou Alltest Biotech Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -8.47% and Operating profit at -24.02% over the last 5 years
2
The company has declared Positive results for the last 4 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at CNY 304.43 MM
  • NET SALES(9M) At CNY 669.64 MM has Grown at 19.52%
  • NET PROFIT(HY) At CNY 153.15 MM has Grown at 62.82%
3
With ROE of 7.13%, it has a attractive valuation with a 0.64 Price to Book Value
  • Over the past year, while the stock has generated a return of -2.92%, its profits have risen by 44.8% ; the PEG ratio of the company is 0.2
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -2.92% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Hangzhou Alltest Biotech Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Hangzhou Alltest Biotech Co., Ltd. for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Hangzhou Alltest Biotech Co., Ltd.
0.84%
0.67
34.28%
China Shanghai Composite
15.44%
1.01
14.52%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-8.47%
EBIT Growth (5y)
-24.02%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.64
Sales to Capital Employed (avg)
0.23
Tax Ratio
12.48%
Dividend Payout Ratio
77.23%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
143.79%
ROE (avg)
16.57%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.64
EV to EBIT
0.14
EV to EBITDA
0.12
EV to Capital Employed
0.03
EV to Sales
0.04
PEG Ratio
0.20
Dividend Yield
NA
ROCE (Latest)
18.48%
ROE (Latest)
7.13%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 304.43 MM

NET SALES(9M)

At CNY 669.64 MM has Grown at 19.52%

NET PROFIT(HY)

At CNY 153.15 MM has Grown at 62.82%

ROCE(HY)

Highest at 8.19%

RAW MATERIAL COST(Y)

Fallen by -14.48% (YoY

-2What is not working for the Company
DEBT-EQUITY RATIO (HY)

Highest at -64.43 %

Here's what is working for Hangzhou Alltest Biotech Co., Ltd.
Net Profit
At CNY 153.15 MM has Grown at 62.82%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Sales
At CNY 669.64 MM has Grown at 19.52%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Operating Cash Flow
Highest at CNY 304.43 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Raw Material Cost
Fallen by -14.48% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hangzhou Alltest Biotech Co., Ltd.
Debt-Equity Ratio
Highest at -64.43 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."